Literature DB >> 19171112

Renal manifestations of the antiphospholipid syndrome.

David D'Cruz1.   

Abstract

The antiphospholipid syndrome is characterized by recurrent arterial and venous thromboses and pregnancy morbidity in association with antiphospholipid antibodies. Recurrent thrombotic events are associated with significant morbidity and mortality. Renal involvement encompasses the whole renal vasculature and may lead to proteinuria, renal impairment, hypertension, and end-stage renal failure. Renal involvement is especially difficult to distinguish from glomerulonephritis when the antiphospholipid syndrome develops in patients with systemic lupus erythematosus. This article reviews the diagnosis and treatment of the major features of this syndrome, with particular reference to the kidney.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19171112     DOI: 10.1007/s11926-009-0008-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  68 in total

1.  Antiphospholipid syndrome and renal artery stenosis.

Authors:  T Godfrey; M A Khamashta; G R Hughes
Journal:  QJM       Date:  2000-02

2.  Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus.

Authors:  J H Stone; W J Amend; L A Criswell
Journal:  Am J Kidney Dis       Date:  1999-12       Impact factor: 8.860

Review 3.  Management of antiphospholipid antibody syndrome: a systematic review.

Authors:  Wendy Lim; Mark A Crowther; John W Eikelboom
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

4.  Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies.

Authors:  L N Prieto; W N Suki
Journal:  Am J Kidney Dis       Date:  1994-04       Impact factor: 8.860

5.  A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).

Authors:  G Finazzi; R Marchioli; V Brancaccio; P Schinco; F Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; T Barbui
Journal:  J Thromb Haemost       Date:  2005-05       Impact factor: 5.824

6.  Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone.

Authors:  K E Moss; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2001-08       Impact factor: 7.580

7.  Validation of the Sapporo criteria for antiphospholipid syndrome.

Authors:  M D Lockshin; L R Sammaritano; S Schwartzman
Journal:  Arthritis Rheum       Date:  2000-02

8.  IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.

Authors:  S Adler; L Szczech; A Qureshi; R Bollu; R Thomas-John
Journal:  Clin Nephrol       Date:  2001-12       Impact factor: 0.975

9.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.

Authors:  H I Glueck; K S Kant; M A Weiss; V E Pollak; M A Miller; M Coots
Journal:  Arch Intern Med       Date:  1985-08

10.  Renal infarction in a severely hypertensive patient with lupus erythematosus and antiphospholipid antibodies.

Authors:  D Hernández; M L Dominguez; F Diaz; M L Fernandez; V Lorenzo; A Rodriguez; A Torres
Journal:  Nephron       Date:  1996       Impact factor: 2.847

View more
  4 in total

Review 1.  Renal involvement in antiphospholipid syndrome.

Authors:  Guillermo J Pons-Estel; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

2.  Prevalence of anti- beta2GPI antibodies and their isotypes in patients with renal diseases and clinical suspicion of antiphospholipid syndrome.

Authors:  Sabiha Anis; Ejaz Ahmed; Rana Muzaffar
Journal:  J Nephropathol       Date:  2013-07-01

3.  Primary antiphospholipid syndrome presenting as thrombotic microangiopathy: Successful treatment with steroids, plasma exchange and anticoagulants.

Authors:  R K Sharma; A Kaul; V Agrawal; K Jaisuresh
Journal:  Indian J Nephrol       Date:  2011-10

Review 4.  The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome.

Authors:  Doruk Erkan; Jane E Salmon
Journal:  Turk J Haematol       Date:  2016-03-05       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.